Skip to content

Drug interactions

Armodafinil + Pioglitazone

Severity: Minor

Armodafinil and Pioglitazone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pioglitazone is metabolized partly by CYP3A4, and armodafinil is a weak inducer of this enzyme. Exposure to pioglitazone may fall slightly, with little expected effect on glucose control.

What this interaction means in plain words

Armodafinil and Pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Armodafinil belongs to Central Nervous System; Pioglitazone belongs to Endocrine.

Evidence level: Low

Why it happens

Weak CYP3A4 induction by armodafinil may increase pioglitazone metabolism.

What to do

No dose change is routinely needed. Check glycemic control if armodafinil is started or stopped.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Armodafinil with Pioglitazone?

MediHelp rates the interaction as minor. Armodafinil and Pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pioglitazone is metabolized partly by CYP3A4, and armodafinil is a weak inducer of this enzyme. Exposure to pioglitazone may fall slightly, with little expected effect on glucose control.

How serious is the interaction between Armodafinil and Pioglitazone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is routinely needed. Check glycemic control if armodafinil is started or stopped.

What other medicines interact with Armodafinil?

MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Elacestrant, Elbasvir / grazoprevir. The full list is on the Armodafinil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in